LTR Pharma (ASX:LTP) Buildings And Improvements: A$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:LTP LTR Pharma Ltd ASX:LTP
6 GF Score
Price A$0.50
View Full Analysis

What is LTR Pharma Buildings And Improvements?

LTR Pharma ASX:LTP +3.09% 6 Buildings And Improvements is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 6/100.

LTR Pharma Buildings And Improvements Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Buildings And Improvements Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Buildings And Improvements
0.00 0.00 0.00 0.00 0.00

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buildings And Improvements Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ASX:LTP
6GF Score
LTR Pharma Ltd ASX:LTP
Buildings And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

What does a Buildings And Improvements of A$0.00 Mil mean?
LTR Pharma (ASX:LTP) has a Buildings And Improvements of A$0.00 Mil as of Dec. 2025. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Buildings And Improvements too high?
LTR Pharma's current Buildings And Improvements is A$0.00 Mil. Overall, LTR Pharma has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Buildings And Improvements compare to VRTX and REGN?
LTR Pharma's Buildings And Improvements of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Biotechnology company?
A good Buildings And Improvements depends on the Biotechnology industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on LTR Pharma and its competitors. LTR Pharma's current Buildings And Improvements is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Buildings And Improvements of A$0.00 Mil. The current Buildings And Improvements is A$0.00 Mil. LTR Pharma's overall GF Score™ is 6/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Buildings And Improvements is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
6GF Score

Get the complete analysis for ASX:LTP

Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.50
Price